Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Lisa M, Pitchford"'
Autor:
Matthew J. O’Neill, Zachary T. Yoneda, Diane M. Crawford, Fei Ye, Mingfang Ao, Lisa M. Pitchford, John A. Rathmacher, Katherine T. Murray, Wendell S. Akers, Dan M. Roden, Gregory F. Michaud, M. Benjamin Shoemaker
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Although catheter ablation is an effective therapy for atrial fibrillation (AF), the most common cardiac arrhythmia encountered in clinical practice, AF ablation generates inflammation and oxidative stress in the early postoperati
Externí odkaz:
https://doaj.org/article/cf7ac91b8865459aa116294be6583ba3
Autor:
Lisa M. Pitchford, Patricia M. Driver, John C. Fuller, Wendell S. Akers, Naji N. Abumrad, Venkataraman Amarnath, Ginger L. Milne, Sheau-Chiann Chen, Fei Ye, L. Jackson Roberts, M. Benjamin Shoemaker, John A. Oates, John A. Rathmacher, Olivier Boutaud
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background 2-Hydroxybenzylamine (2-HOBA) is a selective dicarbonyl electrophile scavenger being developed as a nutritional supplement to help protect against the development of conditions associated with dicarbonyl electrophile formation, su
Externí odkaz:
https://doaj.org/article/aa4bb108a03440a0be1f206802adc5d2
Autor:
Lisa M. Pitchford, John A. Rathmacher, John C. Fuller, J. Scott Daniels, Ryan D. Morrison, Wendall S. Akers, Naji N. Abumrad, Venkataraman Amarnath, Patricia M. Currey, L. Jackson Roberts, John A. Oates, Olivier Boutaud
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background 2-Hydroxybenzylamine (2-HOBA) is a selective scavenger of dicarbonyl electrophiles that protects proteins and lipids from being modified by these electrophiles. It is currently being developed for use as a nutritional supplement t
Externí odkaz:
https://doaj.org/article/7d1b0bf81dba4f70ab70f69755a8bc57
Autor:
Michael W. Schleh, Benjamin J. Ryan, Cheehoon Ahn, Alison C. Ludzki, Pallavi Varshney, Jenna B. Gillen, Douglas W. Van Pelt, Lisa M. Pitchford, Suzette M. Howton, Thomas Rode, Thomas L. Chenevert, Scott L. Hummel, Charles F. Burant, Jeffrey F. Horowitz
Publikováno v:
Obesity. 31:1347-1361
Autor:
Ralf Jäger, Martin Purpura, John A. Rathmacher, John C. Fuller, Jr., Lisa M. Pitchford, Fabricio E. Rossi, Chad M. Kerksick
Publikováno v:
Journal of Functional Foods, Vol 78, Iss , Pp 104357- (2021)
Adenosine triphosphate (ATP) is the primary compound that provides energy to drive many processes in living cells, including muscle contraction, neurotransmission, and cardiac function. Initial research used enteric-coated ATP that displayed no appar
Externí odkaz:
https://doaj.org/article/838be89151de40eb91362ab1e2a05eb6
Autor:
Cheehoon Ahn, Benjamin J. Ryan, Michael W. Schleh, Pallavi Varshney, Alison C. Ludzki, Jenna B. Gillen, Douglas W. Van Pelt, Lisa M. Pitchford, Suzette M. Howton, Thomas Rode, Scott L. Hummel, Charles F. Burant, Jonathan P. Little, Jeffrey F. Horowitz
Publikováno v:
The Journal of Physiology. 600:2127-2146
Excessive adipose tissue mass underlies much of the metabolic health complications in obesity. Although exercise training is known to improve metabolic health in individuals with obesity, the effects of exercise training without weight loss on adipos
Autor:
William D. Fairfield, Dennis M. Minton, Christian J. Elliehausen, Alexander D. Nichol, Taylor L. Cook, John A. Rathmacher, Lisa M. Pitchford, Scott A. Paluska, Adam J. Kuchnia, Jacob M. Allen, Adam R. Konopka
Publikováno v:
Nutrients; Volume 14; Issue 21; Pages: 4674
β-Hydroxy-β-methylbutyrate (HMB), a leucine metabolite, can increase skeletal muscle size and function. However, HMB may be less effective at improving muscle function in people with insufficient Vitamin D3 (25-OH-D < 30 ng/mL) which is common in m
Autor:
Christian J. Elliehausen, William D. Fairfield, Dennis M. Minton, Alex D. Nichol, John A. Rathmacher, Lisa M. Pitchford, Scott A. Paluska, Jacob M. Allen, Adam R. Konopka
Publikováno v:
The FASEB Journal. 36
Publikováno v:
The FASEB Journal. 35
Autor:
Wendell S. Akers, Gregory F. Michaud, Lisa M. Pitchford, Katherine T. Murray, Zachary T. Yoneda, Fei Ye, Diane M. Crawford, Dan M. Roden, John A. Rathmacher, M. Benjamin Shoemaker, Matthew J. O’Neill, Mingfang Ao
Publikováno v:
Trials
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Background Although catheter ablation is an effective therapy for atrial fibrillation (AF), the most common cardiac arrhythmia encountered in clinical practice, AF ablation generates inflammation and oxidative stress in the early postoperative period